Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Vermilion vs Cutaneous Location in cSCC of the Lip

JAMA Dermatology; ePub 2018 May 2; Wang, et al

The risk of nodal metastasis is 5-fold greater for cutaneous squamous cell carcinomas (cSCCs) on the vermilion lip compared with those on the cutaneous lip, according to a recent study. Furthermore, SCCs of the cutaneous lip have a nodal metastasis risk similar to cSCCs in general (1.5%). Researchers conducted a retrospective cohort study of 303 patients with 310 primary cSCCs of the lip (138 cutaneous, 172 vermilion) diagnosed between 2000 and 2015 at 2 academic tertiary care centers in Boston, MA. They found:

  • Of the total study participants with SCCs of the lip, 153 (50.5%) were men, and 150 (49.5%) were women; median age at diagnosis was 68 years (range, 27-93 years).
  • Outcomes were as follows for vermilion vs cutaneous locations: local recurrence, 6.4% (11 of 172) vs 2.9% (4 of 138); nodal metastasis, 7.6% (13 of 172) vs 1.5% (2 of 138); distant metastasis, 0.6% (1 of 172) vs 0.7% (1 of 138); disease-specific death, 3.5% (6 of 172) vs 2.9% (4 of 138); and all-cause death, 26.7% (46 of 172) vs 29.0% (40 of 138).
  • The difference was statistically significant for nodal metastasis.

Citation:

Wang DM, Kraft S, Rohani P, et al. Association of nodal metastasis and mortality with vermilion vs cutaneous lip location in cutaneous squamous cell carcinoma of the lip. [Published online ahead of print May 2, 2018]. JAMA Dermatology. doi:10.1001/jamadermatol.2018.0792.

This Week's Must Reads

Disease Burden of Atopic Dermatitis in the US, J Invest Dermatol; ePub 2018 Oct 30; Chiesa Fuxench, et al

Psoriasis Associated with Sexual Dysfunction, JAMA Dermatol; ePub 2018 Oct 10; Molina-Leyva, et al

Association Between Psoriasis and Suicide Examined, Dermatolog Ther; ePub 2018 Oct 12; Liang, et al

Study: More Than 85% of Surgeons Use Skin Hooks, Dermatolog Surg; ePub 2018 Oct 9; Clark, et al

FDA Approves Hyrimoz for Plaque Psoriasis, Sandoz news release; 2018 Oct 31

Must Reads in Nonmelanoma Skin Cancer

High Risk SCC and Mohs Micrographic Surgery, J Am Acad Dermatol; ePub 2018 Sep 19; Marrazzo, et al

FDA Approves Libtayo for Metastatic cSCC, Sanofi news release; 2018 Sep 28

Incidence of Oral SCC Risk in Oral Lichen Planus, Int J Dermatol; ePub 2018 Sep 14; Lanoisz, et al

Nevus Development Trajectory from Age 3 to 16 Years, JAMA Dermatology; ePub 2018 Sep 12; Asdigian, et al

Evaluation of Combined Detection Method for BCC, JAMA Dermatology; ePub 2018 Aug 22; Sahu, et al